CIBC Private Wealth Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
2,974
+979
| +49% | +$47.6K | ﹤0.01% | 1246 |
|
|
2025
Q1 | $62.4K | Buy |
1,995
+650
| +48% | +$20.3K | ﹤0.01% | 1553 |
|
|
2024
Q4 | $55.5K | Hold |
1,345
| – | – | ﹤0.01% | 1646 |
|
|
2024
Q3 | $63.2K | Hold |
1,345
| – | – | ﹤0.01% | 1687 |
|
|
2024
Q2 | $71.6K | Sell |
1,345
-269
| -17% | -$14.3K | ﹤0.01% | 1528 |
|
|
2024
Q1 | $110K | Sell |
1,614
-10,781
| -87% | -$735K | ﹤0.01% | 1356 |
|
|
2023
Q4 | $776K | Buy |
+12,395
| New | +$776K | ﹤0.01% | 693 |
|
|
2022
Q4 | – | Sell |
-5,520
| Closed | -$361K | – | 872 |
|
|
2022
Q3 | $361K | Hold |
5,520
| – | – | ﹤0.01% | 759 |
|
|
2022
Q2 | $335K | Hold |
5,520
| – | – | ﹤0.01% | 776 |
|
|
2022
Q1 | $346K | Sell |
5,520
-89
| -2% | -$5.58K | ﹤0.01% | 823 |
|
|
2021
Q4 | $425K | Sell |
5,609
-140
| -2% | -$10.6K | ﹤0.01% | 802 |
|
|
2021
Q3 | $643K | Sell |
5,749
-10,575
| -65% | -$1.18M | ﹤0.01% | 696 |
|
|
2021
Q2 | $2.64M | Sell |
16,324
-14,481
| -47% | -$2.34M | 0.01% | 487 |
|
|
2021
Q1 | $3.75M | Buy |
30,805
+24,735
| +407% | +$3.01M | 0.01% | 433 |
|
|
2020
Q4 | $929K | Sell |
6,070
-230
| -4% | -$35.2K | ﹤0.01% | 647 |
|
|
2020
Q3 | $527K | Buy |
+6,300
| New | +$527K | ﹤0.01% | 676 |
|
|
2020
Q2 | – | Sell |
-4,890
| Closed | -$207K | – | 637 |
|
|
2020
Q1 | $207K | Buy |
4,890
+500
| +11% | +$21.2K | ﹤0.01% | 796 |
|
|
2019
Q4 | $267K | Buy |
+4,390
| New | +$267K | ﹤0.01% | 820 |
|
|
2018
Q3 | – | Sell |
-385
| Closed | -$23K | – | 1113 |
|
|
2018
Q2 | $23K | Sell |
385
-140
| -27% | -$8.36K | ﹤0.01% | 1362 |
|
|
2018
Q1 | $24K | Buy |
+525
| New | +$24K | ﹤0.01% | 1341 |
|